Skinvisible, Inc. SKVI Archives - Page 2 of 4

MondayJan 22, 2018 4:17 pm

Skinvisible, Inc. (SKVI) Set to Repeat Olympic Performance in 2018 with DermSafe

Targeting $80 billion global skincare and dermatology market Revenues to be derived from royalties and other licensing fees DermSafe sales have taken off in Greater China Pending merger will expand product offerings Among the winners at the 2016 Summer Olympics in Rio was DermSafe® from Skinvisible’s (OTCQB: SKVI) subsidiary, Kintari. Donated to Team Canada, the non-alcohol hand sanitizing lotion offered protection from pathogens to athletes during the Olympic Games. Now, with the Winter Olympics to be held in South Korea from February 8-25, the need is more pressing. Reported outbreaks of the flu have increased dramatically this year, according to…

FridayJan 19, 2018 12:27 pm

Proposed Merger Expands Skinvisible, Inc. (SKVI) Horizons into Multi-Billion Dollar Pain Market

Company has developed and licensed novel drug delivery systems and products for over 15 years With 14 patents, Skinvisible has proven efficacy and global reach Proposed merger may transform non-opioid pain market At the cutting edge of innovative drug delivery technology since 1999, Skinvisible, Inc. (OTCQB: SKVI), in a recently announced Letter of Intent of a proposed merger with Quoin Pharmaceuticals, is now expanding its horizons into the global pain management therapeutics market. The pain management therapeutics market is projected to expand at a 3.7 percent CAGR and exceed $83 billion in the United States by 2024 (http://ibn.fm/1wGbq). Skinvisible, through…

WednesdayJan 10, 2018 12:55 pm

QualityStocksNewsBreaks – Skinvisible, Inc. (SKVI) and Quoin Pharmaceuticals to Provide Opioid-free Pain Relief Solution

Topical and transdermal product development company Skinvisible (OTCQB: SKVI), through its recently entered non-binding merger agreement with Quoin Pharmaceuticals Limited, is planning to create a solution to the opioid crisis that is currently plaguing America. An article discussing this reads: “In response to the substance abuse epidemic sweeping the nation, Congress passed the 21st Century Cures Act, which was signed into law by President Obama in December 2016. The legislation allocates over $1 billion to a variety of programs, some of which will attempt to wean patients away from addictive opium derivatives, a push unlikely to cause any degradation in…

MondayJan 08, 2018 4:19 pm

Skinvisible, Inc. (SKVI) Proposed Merger with Quoin to Provide 21st Century Cures

Substance use disorder (SUD) has reached crisis proportions Deal links Quoin’s non-opioid analgesics to Skinvisible’s drug delivery system Market for opioids is currently about $6 billion annually Opioids are killing Americans at an alarming rate. Every day ‘91 Americans die… from an opioid overdose’, according to the Centers for Disease Control and Prevention (CDC). In response to the substance abuse epidemic sweeping the nation, Congress passed the 21st Century Cures Act, which was signed into law by President Obama in December 2016. The legislation allocates over $1 billion to a variety of programs, some of which will attempt to wean…

FridayJan 05, 2018 1:00 pm

QualityStocksNewsBreaks – Skinvisible, Inc. (SKVI) Could Create Non-opioid Pain Solution for Rising Population of Senior Citizens

Skinvisible (OTCQB: SKVI), a topical and transdermal product development company, recently entered a non-binding merger with Quoin Pharmaceuticals Limited. The two companies are expected to deliver a non-opioid solution to pain sufferers. An article discussing this reads: “Health professionals are preparing for an expected doubling of the 65 years and older population within the next 30 years, creating medical need to address the pain that often becomes a prevalent companion to age. While modern pharmaceuticals have developed opioids and non-steroidal therapies for reducing chronic pain, the drugs are often accompanied by addiction and unwanted side effect concerns. However, Skinvisible, Inc.’s…

FridayDec 29, 2017 3:04 pm

Skinvisible, Inc. (SKVI) Partnership with Quoin Focuses on Population’s Pain Needs

Non-binding proposed merger announced on November 27, 2017 Quoin merger expected to deliver non-opioid relief to post-surgical patients Over-65 population with advanced pain needs expected to double within next 30 years Skinvisible and Quoin proposed merger expected to deliver better results to patients Health professionals are preparing for an expected doubling of the 65 years and older population within the next 30 years, creating medical need to address the pain that often becomes a prevalent companion to age. While modern pharmaceuticals have developed opioids and non-steroidal therapies for reducing chronic pain, the drugs are often accompanied by addiction and unwanted…

FridayDec 29, 2017 1:05 pm

QualityStocksNewsBreaks – Skinvisible, Inc. (SKVI) Prepares to Address Killer Drug Epidemic Through Proposed Merger Agreement

Topical and transdermal product development company Skinvisible (OTCQB: SKVI) recently signed a letter of intent regarding a proposed merger with Quoin Pharmaceuticals Limited. The two companies intend to work together to address the opioid epidemic plaguing America. An article discussing this reads: “There are increased incentives and growing public and FDA/government demands to address the crisis. Innovators vying to meet critical needs and to combat the opioid issue with alternative, non-addictive and effective products include Skinvisible, Inc. (OTCQB: SKVI) and Quoin Pharmaceuticals Limited. As announced earlier this month, the two companies have entered a Letter of Intent for a proposed…

ThursdayDec 28, 2017 1:59 pm

Skinvisible, Inc. (SKVI) and Quoin Poised to Tackle Opioid Crisis with Alternative Pain Therapies

A possible larger role for leading drug manufacturers, and the resulting opioid epidemic, is met with increased public and government demands for alternative therapies The Skinvisible and Quoin merger, with expected completion in 2018, will create an enterprise positioned to disrupt the $6 billion U.S. opioid market by producing and delivering non-opioid alternatives for pain management Quoin’s QRX001 is slated to provide alternative and effective pain management in the post-surgical setting, where 50 percent of opioid addictions start A recent article by the Washington Post (http://dtn.fm/cGzr2) addressed the opioid crisis, suggesting a larger role by leading pharmaceutical drug manufacturers than…

ThursdayDec 21, 2017 1:47 pm

QualityStocksNewsBreaks – Skinvisible, Inc. (SKVI) May Target Booming Pain Management Market Through Proposed Merger with Quoin Pharmaceuticals

Topical and transdermal product development company Skinvisible (OTCQB: SKVI) recently signed a Letter of Intent (“LOI”) regarding a proposed merger with Quoin Pharmaceuticals Limited. The potential partnership could target significant unmet medical needs on the pain management market. An article discussing this reads: “Currently, the pain management market in the U.S. is fueled by a number of sectors. The most prominent ones include post-operative pain relief, arthritis pain, cancer pain, migraine and neuropathic pain. As larger Western populations age and become susceptible to an array of medical conditions, the need for new pain management developments will grow even larger. The…

MondayDec 18, 2017 10:30 am

Proposed Skinvisible (SKVI), Quoin Pharmaceuticals Merger to Address Opioid Pain Management Market

A merger between Skinvisible and Quoin Pharmaceuticals will enable a successful entry on the post-surgical pain management market Aging populations and a large number of surgical interventions in the West have contributed to significant market expansion By 2024, the pain management therapeutics market is expected to reach $83 billion Skinvisible Pharmaceuticals (OTCQB: SKVI) recently announced that it has signed a Letter of Intent for a proposed merger with Quoin Pharmaceuticals Limited – a partnership that could address significant unmet medical needs on the pain management market. If both parties agree on the terms, the merger should be completed next year,…

Site Search

Company Search

Tag: Skinvisible, Inc. SKVI